Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyâ
2026-03-16ADPT144ROBINS CHAD M plan to sell securities of Adaptive Biotechnologies Corp under Form 144MEDIUM
ROBINS CHAD M filed Form 144 to notify SEC of plan to sell 470167 units of Adaptive Biotechnologies Corp securities around 2026-03-11, with aggregate market value of $6,826,824.84. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.31% of total outstanding units; Recent transactions ...
Mid CapBiotechnology
2026-03-16ADPT144PISKEL KYLE plan to sell securities of Adaptive Biotechnologies Corp under Form 144MEDIUM
PISKEL KYLE filed Form 144 to notify SEC of plan to sell 18672 units of Adaptive Biotechnologies Corp securities around 2026-03-11, with aggregate market value of $271,117.44. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in pa...
Mid CapBiotechnology
2026-03-16ADPT144RUBINSTEIN JULIE plan to sell securities of Adaptive Biotechnologies Corp under Form 144MEDIUM
RUBINSTEIN JULIE filed Form 144 to notify SEC of plan to sell 122523 units of Adaptive Biotechnologies Corp securities around 2026-03-11, with aggregate market value of $1,779,033.96. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.08% of total outstanding units; Recent transactio...
Mid CapBiotechnology
2026-03-16ADPT144ROBINS HARLAN S plan to sell securities of Adaptive Biotechnologies Corp under Form 144MEDIUM
ROBINS HARLAN S filed Form 144 to notify SEC of plan to sell 470266 units of Adaptive Biotechnologies Corp securities around 2026-03-11, with aggregate market value of $6,828,262.32. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.31% of total outstanding units; Recent transaction...
Mid CapBiotechnology
2026-03-16ADPT144BENZENO SHARON plan to sell securities of Adaptive Biotechnologies Corp under Form 144MEDIUM
BENZENO SHARON filed Form 144 to notify SEC of plan to sell 63103 units of Adaptive Biotechnologies Corp securities around 2026-03-11, with aggregate market value of $916,255.56. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.04% of total outstanding units; ...
Mid CapBiotechnology
2026-03-16ADPT144BOBULSKY SUSAN plan to sell securities of Adaptive Biotechnologies Corp under Form 144MEDIUM
BOBULSKY SUSAN filed Form 144 to notify SEC of plan to sell 41338 units of Adaptive Biotechnologies Corp securities around 2026-03-11, with aggregate market value of $600,227.76. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.03% of total outstanding units; ...
Mid CapBiotechnology
2026-03-16ALLO144Chang David D plan to sell securities of Allogene Therapeutics, Inc. under Form 144MEDIUM
Chang David D filed Form 144 to notify SEC of plan to sell 47763 units of Allogene Therapeutics, Inc. securities around 2026-03-16, with aggregate market value of $117,826.97. The total outstanding units is 243777920.0. The amount planned to be sold represents 0.02% of total outstanding units; ...
Small CapBiotechnology
Sponsored
2026-03-16ALLO144Beneski Benjamin Machinas plan to sell securities of Allogene Therapeutics, Inc. under Form 144MEDIUM
Beneski Benjamin Machinas filed Form 144 to notify SEC of plan to sell 4835 units of Allogene Therapeutics, Inc. securities around 2026-03-16, with aggregate market value of $11,927.50. The total outstanding units is 243777920.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Small CapBiotechnology